News and Updates

USCACA partner --CJC Wins the Title of 2013’ the Highest International Impact Academic Journal of China

"As the partner of the Chinese Journal of Cancer (CJC) for the past 3 years, USCACA is proud to announce that our society journal CJC wins the Title of 2013’s Highest International Impact Academic Journal of China. Below is a news release from Sun Yat-sen University where CJC is headquartered. Members of USCACA have organized a number of special issues on important topics including Cancer Drug Discovery, Systems Biology of Cancer, Cancer Autophagy, Mouse Model of Cancer, Signaling pathways of Cancer."

Four outstanding young Chinese scientists received the 2013 Scholar Award from USCACA and NFCR

To facilitate and strengthen collaborations among cancer researchers and physicians in the United States and China, the US Chinese Anti-Cancer Association (USCACA) and the National Foundation for Cancer Research (NFCR) have established the Scholar Excellence Award for the USCACA-NFCR Scholar Exchange and Fellowship Program in Basic, Translational, and Clinical Studies.

USCACA partner -- The Chinese Journal of Cancer is supported by the International Impact-promoting Program for Chinese Sci-Tech Journals

Recently, the International Impact-promoting Program for Chinese Sci-Tech Journals has released the journal selection results. The Chinese Journal of Cancer (CJC), an English journal sponsored by Sun Yat-sen University Cancer Center, gained type B grant support from this program, with an annual national funding of 1,000,000 RMB for 3 consecutive years.

USCACA committee members with Dr. Zhu Chen at 2013 SZENT-GYÖRGYI PRIZE CEREMONY OF NFCR

USCACA sponsored a table at the 2013 Szent-Gyorgyi Prize Ceremony of the National Foundation for Cancer Research (NFCR). This year, the prestigious award went to Alex Matter, M.D., CEO of the Experimental Therapeutic Centre of Agency for Science, Technology and Research (A*STAR) in Singapore, Member of the Swiss Academy of Medical Sciences. The award recognizes his tremendous contribution in the development of Gleevec. Dr.

US China Anti-Cancer Association on Facebook

Check out USCACA on Facebook:
https://www.facebook.com/groups/575928855773109/

Or search:
US Chinese Anti- Cancer Association

USCACA President Wei Zhang and NFCR COO Sujuan Ba visited Xinxiang Medical University

Dr. Wei Zhang, the President of the US Chinese Anti-cancer Association (USCACA), Dr.S ujuan Ba, the Chief Operating Officer of National Foundation for Cancer Research (NFCR), Dr. Kexin Chen, Director of the Department of Epidemiology and Director of Tissue Bank, Tianjin Medical University Cancer Institute and Hospital, visited Xinxiang Medical University on September 10, 2012.

USCACA hosted a symposium in the 7th Chinese Conference on Oncology (CCO)

Beijing, September 8. Invited by Chinese Anti-Cancer Association, USCACA hosted a special symposium on Collaboration between US and China in Cancer Research. Drs. Wei Zhou and Wancai Yang chaired the symposium. Six experts from US and China (Yunguang Tong, Shi-Yuan Cheng, Zhimin Lv, Wancai Yang, Biao He and Jianmin Fang) introduced their own research and shared experience in a series of topics, including scientific training and career development in US, the difference of research environment, and traps in international collaboration. Drs.

Session Chairs
Session Chairs
Session Chairs

USCACA in the news

USCACA is featured in the Applied Clinical Trials:

http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/CRO%2FS...
http://digital.findpharma.com/nxtbooks/advanstar/act_201209/#/14

Click on the links for more information.

Pages

Subscribe to RSS - News and Updates